PerpEquitiesTop analysts on stock perps · Analyst
Jasper Hellweg (Argus Research): analyst track record on stock perps
Jasper Hellweg of Argus Research on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.1★
Success57%
Excess return+7.5%
rank#2,190
Ratings199
ratings on stock perps59
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 45 | 109 |
| Stock | 31 | 41 |
| Buy / hold / sell | 28 / 17 / 0 | 77 / 32 / 0 |
| Upgrades / downgrades / initiations | 5 / 3 / 0 | 9 / 8 / 0 |
| Price targets hit / missed | 5 / 20 (20%) | 28 / 38 (42%) |
| Avg. return after a rating (TipRanks) | -12.1% | -0.6% |
| Best / worst call | +11.5% / -47.9% | +101.3% / -72.5% |
After buy calls: median 21-day move +2.3% · vs S&P 500 +0.3% · targets hit within a year 72% (n = 53)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $MRNA Moderna, Inc. | Buy · Upgraded | $180 | +31.8% | Aug 27, 2026 |
| $MRK Merck & Co., Inc. | Buy · Reiterated | $170 | +17.5% | Aug 24, 2026 |
| $AMGN Amgen Inc. | Buy · Reiterated | $460 | +20.3% | Aug 18, 2026 |
| $NVO Novo Nordisk A/S | Hold · Maintained | – | – | Aug 7, 2026 |
| $BMY Bristol Myers Squibb | Buy · Upgraded | $75.00 | +17.6% | Aug 4, 2026 |
| $NVS Novartis AG | Buy · Maintained | $170 | +23.7% | Jul 24, 2026 |
| $BIIB Biogen Inc. | Hold · Maintained | – | – | Jul 10, 2026 |
| $ABBV AbbVie Inc. | Buy · Reiterated | $250 | -2.0% | May 13, 2026 |
Recent ratings
- Aug 27, 2026 $MRNA: Upgraded · Buy · $180 · article
- Aug 24, 2026 $MRK: Reiterated · Buy · $170 · article
- Aug 18, 2026 $AMGN: Reiterated · Buy · $460 · article
- Aug 10, 2026 $MRK: Reiterated · Buy · $145 · article
- Aug 7, 2026 $NVO: Maintained · Hold · article
- Aug 4, 2026 $BMY: Upgraded · Buy · $75.00 · article
- Jul 24, 2026 $NVS: Maintained · Buy · $170 · article
- Jul 10, 2026 $BIIB: Maintained · Hold · article
- Jun 4, 2026 $NVS: Reiterated · Buy · $160 · article
- May 13, 2026 $ABBV: Reiterated · Buy · $250 · article
- May 8, 2026 $MRK: Reiterated · Buy · $130 · article
- Mar 20, 2026 $NVO: Maintained · Hold · article
- Jan 13, 2026 $MRNA: Reiterated · Hold · article
- Jan 9, 2026 $BIIB: Maintained · Hold · article
- Jan 9, 2026 $BIIB: Maintained · Hold
- Jan 7, 2026 $BMY: Maintained · Hold · article
- Dec 5, 2025 $NVO: Downgraded · Hold · article
- Aug 29, 2025 $MRNA: Reiterated · Hold · article
- Jun 30, 2025 $REGN: Downgraded · Hold · article
- Jun 18, 2025 $NVO: Reiterated · Buy · $90.00 · article
Jasper Hellweg4.1★ · 57% success · +7.5% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.